Skip to content
Screener

Grace Therapeutics, Inc. GRCE Q1 2026 Annual earnings

Reported June 18, 2026 · Before market open

EPS-$0.07Beat by $0.17
Revenue estimate$900.0K
EPS estimate-$0.24

Next report

Nov 12, 2026 (in 2 months)
Revenue estimate$1.0M
EPS estimate-$0.15

FAQ

When did Grace Therapeutics, Inc. report Q1 2026 earnings?
Grace Therapeutics, Inc. (GRCE) reported Q1 2026 earnings on June 18, 2026 before market open.
What were Grace Therapeutics, Inc.'s Q1 2026 revenue and EPS?
Grace Therapeutics, Inc. reported eps of $-0.07 for Q1 2026.
Did Grace Therapeutics, Inc. beat estimates in Q1 2026?
EPS beat the consensus estimate of $-0.24 by $0.17.
How did Grace Therapeutics, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 66.7% from $-0.21.
Where can I find Grace Therapeutics, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001140361-26-025667) and the 10-K periodic report (0001140361-26-025662) directly on SEC EDGAR. The filing index links above go to sec.gov.